Christian Meisel

Christian Meisel, MD PhD, is Co-Founder and Chief Medical Officer of Hedera Dx, a techbio company dedicated to improving outcomes for patients and to removing barriers to access to precision medicine in oncology.
Christian Meisel is a Physician Scientist (Charité, Berlin), and board-certified in Internal Medicine and Clinical Pharmacology. His academic work has resulted in >40 peer-reviewed original publications, and patent application on AI-driven drug-response prediction.
Throughout his career, Christian Meisel has championed Translational Medicine and Drug Development, Molecular Diagnostics, and Real-World Evidence, with a passion for applying AI to optimise drug development and precision medicine.
Before launching Hedera Dx, Christian Meisel served over 15 years at Roche in global leadership roles in Translational Medicine, Oncology Biomarkers, and Personalized Healthcare Platforms, and most recently as Chief Medical Officer of Molecular Health.